Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-20
    E.g., 2018-10-20

Archive Search

1 results
12:00 AM, Sep 10, 2009  |  BC Innovations | Distillery Therapeutics

Indication: Pulmonary disease

bronchoconstriction-associated conditions. GlaxoSmithKline plc has two muscarinic acetylcholine antagonists in Phase II testing for COPD: darotropium